![AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance](https://www.harmony-alliance.eu/webimages/CONTENT%202021-1/PROJECTS/Afbeelding1.jpg)
AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance
![Barbara Knight Foundation Hosts Inaugural Gala To Raise Funds for Patients with Acute Myeloid Leukemia | Miami's Community News Barbara Knight Foundation Hosts Inaugural Gala To Raise Funds for Patients with Acute Myeloid Leukemia | Miami's Community News](https://communitynewspapers.com/wp-content/uploads/2023/02/f78edf_ffd64c1afa37461d825fcc111c39cfe2_mv2.png)
Barbara Knight Foundation Hosts Inaugural Gala To Raise Funds for Patients with Acute Myeloid Leukemia | Miami's Community News
![Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes](https://cancer.osu.edu/-/media/images/shared/media-room/cancer/press-releases/2016/october/lls-partner-logos-graphic.jpg)
Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes
MDS Foundation, Inc. - AML World Awareness Day! Want to learn more about Acute Myeloid Leukemia (AML), but not a fan of reading long articles? Watch our You and AML animated video
![A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia | Nature Communications A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-22625-y/MediaObjects/41467_2021_22625_Fig1_HTML.png)
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia | Nature Communications
![New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-020-00376-1/MediaObjects/41408_2020_376_Fig1_HTML.png)
New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal
![Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis: Trends in Cell Biology Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis: Trends in Cell Biology](https://www.cell.com/cms/attachment/8d08f9b2-48bc-40e0-8598-e92635cf8845/gr1_lrg.jpg)
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis: Trends in Cell Biology
![Foundation for the National Institutes of Health on Twitter: "Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD) Foundation for the National Institutes of Health on Twitter: "Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD)](https://pbs.twimg.com/media/FLFfeWjUYAgLofF.jpg:large)